跨性别患者的性别确认激素治疗:对血栓形成风险的影响
Hannah King1, Thalia Padilla Kelley1, Joseph J Shatzel2,3
1Department of Internal Medicine, Oregon Health & Science University, Portland, OR.
对跨性别个人的性别肯定激素治疗有新兴的血液风险,包括雌激素的血栓形成和的多细胞血症. 仔细监测和个性化管理对于安全有效的护理至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
- 跨性别者健康 跨性别者健康
背景情况:
- 跨性别个体的性别肯定激素治疗 (GAHT) 的血液病后效应研究不足.
- 对跨性别女性的雌激素治疗显示出可变的不良影响,受剂量和配方的影响.
- 跨性别和性别多样性个体的血栓形成风险是多因素的.
研究的目的:
- 审查当前对与跨性别人士的雌激素和治疗相关的血液风险的理解.
- 突出这一群体中激素治疗的个性化管理策略的重要性.
- 确定需要进一步研究的领域,以优化血液学结果.
主要方法:
- 对跨性别人群中GAHT血液学影响研究的文献综述.
- 对静脉血栓栓塞瘤 (VTE) 的血栓塞瘤风险因素和管理策略的分析在雌激素的变性人群中.
- 检查与丸激素治疗相关的不良影响,包括多细胞血症和铁缺乏症.
主要成果:
- 雌激素治疗具有可变的血栓形成风险,需要标准抗凝药和共享VTE管理决策.
- 性别肯定性丸激素治疗与低血栓风险相关,但常见的副作用包括多细胞血症和潜在的铁缺乏症.
- 高激素增高激素的好处,如降低抑郁和自杀风险,强调需要仔细管理VTE后的荷尔蒙疗法.
结论:
- 目前关于跨性别人群中GAHT的血液学后果的数据正在扩大,但有限.
- 进一步的研究对于完善管理策略和改善激素治疗中跨性别患者的血液学结果至关重要.
- 需要一个细微的方法,平衡GAHT的好处与潜在的血液风险.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:37Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
Published on: August 16, 2024
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
